Global CAR T-Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global CAR T-Cell Therapy market size was valued at US$ 4205 million in 2023 and is forecast to a readjusted size of USD 21660 million by 2030 with a CAGR of 25.4% during review period.
CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is an innovative form of immunotherapy that involves genetically modifying a patient?s own T cells to express a specific chimeric antigen receptor (CAR) on their surface. This receptor enables the T cells to target and destroy cancer cells effectively. CAR-T therapy has shown significant success in treating hematological malignancies, such as acute lymphoblastic leukemia (ALL) and certain types of lymphomas, and is being explored for its potential applications in solid tumors.
The CAR-T Cell Therapy market is primarily driven by its groundbreaking effectiveness in treating certain types of hematological malignancies, such as acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL), particularly in patients who are refractory to standard treatments. The rising incidence of cancer globally and the growing demand for personalized and targeted therapies have further fueled market growth. In addition, advancements in genetic engineering and manufacturing processes are making CAR-T therapies safer, more efficient, and increasingly accessible. The strong support from government initiatives and private investments in oncology research is also accelerating the development of next-generation CAR-T products, expanding their therapeutic potential to include solid tumors.However, the market faces significant challenges, including the high cost of CAR-T therapies, which can exceed hundreds of thousands of dollars per treatment, making it inaccessible to many patients. The complex and time-consuming manufacturing process, which involves extracting and engineering a patient?s T cells, further contributes to these high costs. Additionally, CAR-T therapy is associated with severe side effects, such as cytokine release syndrome (CRS) and neurotoxicity, which require specialized management and can limit its broader adoption. Regulatory hurdles and the need for improved scalability also present obstacles, particularly in developing regions where healthcare infrastructure may be inadequate to support this advanced therapy.
The global top three CAR T-Cell therapy players include Novartis, Gilead Sciences, Bristol-Myers Squibb, with a total market share of more than 99%. The largest player is Gilead Sciences, with a market share of over 50%. North America is the global most important consumer market for CAR T-Cell therapy, with a market share of more than 65%. In terms of type, CD19-targeted CAR cell therapy has a market share of over 90%. In the field of application, the market share of lymphoma exceeds 90%.
This report is a detailed and comprehensive analysis for global CAR T-Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global CAR T-Cell Therapy market size and forecasts, in consumption value ($ Million), 2019-2030
Global CAR T-Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global CAR T-Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global CAR T-Cell Therapy market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR T-Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR T-Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CAR T-Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- CD19 - Targeted
- BCMA - Targeted
Market segment by Application
- Lymphoma
- Multiple Myeloma
Market segment by players, this report covers
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J & J
- JW Therapeutics
- FOSUNKite
- CARsgen Therapeutics (Pipeline)
- Autolus Therapeutics(Pipeline)
- Sorrento Therapeutics(Pipeline)
- Mustang Bio(Pipeline)
- Bluebird Bio(Pipeline)
- Cellectis(Pipeline)
- Allogene Therapeutics(Pipeline)
- Celyad(Pipeline)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR T-Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR T-Cell Therapy, with revenue, gross margin, and global market share of CAR T-Cell Therapy from 2019 to 2024.
Chapter 3, the CAR T-Cell Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CAR T-Cell Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-Cell Therapy.
Chapter 13, to describe CAR T-Cell Therapy research findings and conclusion.
CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is an innovative form of immunotherapy that involves genetically modifying a patient?s own T cells to express a specific chimeric antigen receptor (CAR) on their surface. This receptor enables the T cells to target and destroy cancer cells effectively. CAR-T therapy has shown significant success in treating hematological malignancies, such as acute lymphoblastic leukemia (ALL) and certain types of lymphomas, and is being explored for its potential applications in solid tumors.
The CAR-T Cell Therapy market is primarily driven by its groundbreaking effectiveness in treating certain types of hematological malignancies, such as acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL), particularly in patients who are refractory to standard treatments. The rising incidence of cancer globally and the growing demand for personalized and targeted therapies have further fueled market growth. In addition, advancements in genetic engineering and manufacturing processes are making CAR-T therapies safer, more efficient, and increasingly accessible. The strong support from government initiatives and private investments in oncology research is also accelerating the development of next-generation CAR-T products, expanding their therapeutic potential to include solid tumors.However, the market faces significant challenges, including the high cost of CAR-T therapies, which can exceed hundreds of thousands of dollars per treatment, making it inaccessible to many patients. The complex and time-consuming manufacturing process, which involves extracting and engineering a patient?s T cells, further contributes to these high costs. Additionally, CAR-T therapy is associated with severe side effects, such as cytokine release syndrome (CRS) and neurotoxicity, which require specialized management and can limit its broader adoption. Regulatory hurdles and the need for improved scalability also present obstacles, particularly in developing regions where healthcare infrastructure may be inadequate to support this advanced therapy.
The global top three CAR T-Cell therapy players include Novartis, Gilead Sciences, Bristol-Myers Squibb, with a total market share of more than 99%. The largest player is Gilead Sciences, with a market share of over 50%. North America is the global most important consumer market for CAR T-Cell therapy, with a market share of more than 65%. In terms of type, CD19-targeted CAR cell therapy has a market share of over 90%. In the field of application, the market share of lymphoma exceeds 90%.
This report is a detailed and comprehensive analysis for global CAR T-Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global CAR T-Cell Therapy market size and forecasts, in consumption value ($ Million), 2019-2030
Global CAR T-Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global CAR T-Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global CAR T-Cell Therapy market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR T-Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR T-Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CAR T-Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- CD19 - Targeted
- BCMA - Targeted
Market segment by Application
- Lymphoma
- Multiple Myeloma
Market segment by players, this report covers
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J & J
- JW Therapeutics
- FOSUNKite
- CARsgen Therapeutics (Pipeline)
- Autolus Therapeutics(Pipeline)
- Sorrento Therapeutics(Pipeline)
- Mustang Bio(Pipeline)
- Bluebird Bio(Pipeline)
- Cellectis(Pipeline)
- Allogene Therapeutics(Pipeline)
- Celyad(Pipeline)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR T-Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR T-Cell Therapy, with revenue, gross margin, and global market share of CAR T-Cell Therapy from 2019 to 2024.
Chapter 3, the CAR T-Cell Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CAR T-Cell Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-Cell Therapy.
Chapter 13, to describe CAR T-Cell Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CAR T-Cell Therapy by Type
1.3.1 Overview: Global CAR T-Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global CAR T-Cell Therapy Consumption Value Market Share by Type in 2023
1.3.3 CD19 - Targeted
1.3.4 BCMA - Targeted
1.4 Global CAR T-Cell Therapy Market by Application
1.4.1 Overview: Global CAR T-Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Lymphoma
1.4.3 Multiple Myeloma
1.5 Global CAR T-Cell Therapy Market Size & Forecast
1.6 Global CAR T-Cell Therapy Market Size and Forecast by Region
1.6.1 Global CAR T-Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global CAR T-Cell Therapy Market Size by Region, (2019-2030)
1.6.3 North America CAR T-Cell Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe CAR T-Cell Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific CAR T-Cell Therapy Market Size and Prospect (2019-2030)
1.6.6 South America CAR T-Cell Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa CAR T-Cell Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis CAR T-Cell Therapy Product and Solutions
2.1.4 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR T-Cell Therapy Product and Solutions
2.2.4 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Product and Solutions
2.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 J & J
2.4.1 J & J Details
2.4.2 J & J Major Business
2.4.3 J & J CAR T-Cell Therapy Product and Solutions
2.4.4 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 J & J Recent Developments and Future Plans
2.5 JW Therapeutics
2.5.1 JW Therapeutics Details
2.5.2 JW Therapeutics Major Business
2.5.3 JW Therapeutics CAR T-Cell Therapy Product and Solutions
2.5.4 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 JW Therapeutics Recent Developments and Future Plans
2.6 FOSUNKite
2.6.1 FOSUNKite Details
2.6.2 FOSUNKite Major Business
2.6.3 FOSUNKite CAR T-Cell Therapy Product and Solutions
2.6.4 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 FOSUNKite Recent Developments and Future Plans
2.7 CARsgen Therapeutics (Pipeline)
2.7.1 CARsgen Therapeutics (Pipeline) Details
2.7.2 CARsgen Therapeutics (Pipeline) Major Business
2.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product and Solutions
2.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
2.8 Autolus Therapeutics(Pipeline)
2.8.1 Autolus Therapeutics(Pipeline) Details
2.8.2 Autolus Therapeutics(Pipeline) Major Business
2.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
2.8.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Autolus Therapeutics(Pipeline) Recent Developments and Future Plans
2.9 Sorrento Therapeutics(Pipeline)
2.9.1 Sorrento Therapeutics(Pipeline) Details
2.9.2 Sorrento Therapeutics(Pipeline) Major Business
2.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
2.9.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sorrento Therapeutics(Pipeline) Recent Developments and Future Plans
2.10 Mustang Bio(Pipeline)
2.10.1 Mustang Bio(Pipeline) Details
2.10.2 Mustang Bio(Pipeline) Major Business
2.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
2.10.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Mustang Bio(Pipeline) Recent Developments and Future Plans
2.11 Bluebird Bio(Pipeline)
2.11.1 Bluebird Bio(Pipeline) Details
2.11.2 Bluebird Bio(Pipeline) Major Business
2.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
2.11.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bluebird Bio(Pipeline) Recent Developments and Future Plans
2.12 Cellectis(Pipeline)
2.12.1 Cellectis(Pipeline) Details
2.12.2 Cellectis(Pipeline) Major Business
2.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Product and Solutions
2.12.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Cellectis(Pipeline) Recent Developments and Future Plans
2.13 Allogene Therapeutics(Pipeline)
2.13.1 Allogene Therapeutics(Pipeline) Details
2.13.2 Allogene Therapeutics(Pipeline) Major Business
2.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
2.13.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Allogene Therapeutics(Pipeline) Recent Developments and Future Plans
2.14 Celyad(Pipeline)
2.14.1 Celyad(Pipeline) Details
2.14.2 Celyad(Pipeline) Major Business
2.14.3 Celyad(Pipeline) CAR T-Cell Therapy Product and Solutions
2.14.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Celyad(Pipeline) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global CAR T-Cell Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of CAR T-Cell Therapy by Company Revenue
3.2.2 Top 3 CAR T-Cell Therapy Players Market Share in 2023
3.2.3 Top 6 CAR T-Cell Therapy Players Market Share in 2023
3.3 CAR T-Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 CAR T-Cell Therapy Market: Region Footprint
3.3.2 CAR T-Cell Therapy Market: Company Product Type Footprint
3.3.3 CAR T-Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global CAR T-Cell Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global CAR T-Cell Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global CAR T-Cell Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America CAR T-Cell Therapy Consumption Value by Type (2019-2030)
6.2 North America CAR T-Cell Therapy Market Size by Application (2019-2030)
6.3 North America CAR T-Cell Therapy Market Size by Country
6.3.1 North America CAR T-Cell Therapy Consumption Value by Country (2019-2030)
6.3.2 United States CAR T-Cell Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada CAR T-Cell Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe CAR T-Cell Therapy Consumption Value by Type (2019-2030)
7.2 Europe CAR T-Cell Therapy Consumption Value by Application (2019-2030)
7.3 Europe CAR T-Cell Therapy Market Size by Country
7.3.1 Europe CAR T-Cell Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7.3.3 France CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Region
8.3.1 Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2019-2030)
8.3.2 China CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.5 India CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America CAR T-Cell Therapy Consumption Value by Type (2019-2030)
9.2 South America CAR T-Cell Therapy Consumption Value by Application (2019-2030)
9.3 South America CAR T-Cell Therapy Market Size by Country
9.3.1 South America CAR T-Cell Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil CAR T-Cell Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina CAR T-Cell Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Country
10.3.1 Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey CAR T-Cell Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE CAR T-Cell Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 CAR T-Cell Therapy Market Drivers
11.2 CAR T-Cell Therapy Market Restraints
11.3 CAR T-Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 CAR T-Cell Therapy Industry Chain
12.2 CAR T-Cell Therapy Upstream Analysis
12.3 CAR T-Cell Therapy Midstream Analysis
12.4 CAR T-Cell Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CAR T-Cell Therapy by Type
1.3.1 Overview: Global CAR T-Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global CAR T-Cell Therapy Consumption Value Market Share by Type in 2023
1.3.3 CD19 - Targeted
1.3.4 BCMA - Targeted
1.4 Global CAR T-Cell Therapy Market by Application
1.4.1 Overview: Global CAR T-Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Lymphoma
1.4.3 Multiple Myeloma
1.5 Global CAR T-Cell Therapy Market Size & Forecast
1.6 Global CAR T-Cell Therapy Market Size and Forecast by Region
1.6.1 Global CAR T-Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global CAR T-Cell Therapy Market Size by Region, (2019-2030)
1.6.3 North America CAR T-Cell Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe CAR T-Cell Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific CAR T-Cell Therapy Market Size and Prospect (2019-2030)
1.6.6 South America CAR T-Cell Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa CAR T-Cell Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis CAR T-Cell Therapy Product and Solutions
2.1.4 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR T-Cell Therapy Product and Solutions
2.2.4 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Product and Solutions
2.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 J & J
2.4.1 J & J Details
2.4.2 J & J Major Business
2.4.3 J & J CAR T-Cell Therapy Product and Solutions
2.4.4 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 J & J Recent Developments and Future Plans
2.5 JW Therapeutics
2.5.1 JW Therapeutics Details
2.5.2 JW Therapeutics Major Business
2.5.3 JW Therapeutics CAR T-Cell Therapy Product and Solutions
2.5.4 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 JW Therapeutics Recent Developments and Future Plans
2.6 FOSUNKite
2.6.1 FOSUNKite Details
2.6.2 FOSUNKite Major Business
2.6.3 FOSUNKite CAR T-Cell Therapy Product and Solutions
2.6.4 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 FOSUNKite Recent Developments and Future Plans
2.7 CARsgen Therapeutics (Pipeline)
2.7.1 CARsgen Therapeutics (Pipeline) Details
2.7.2 CARsgen Therapeutics (Pipeline) Major Business
2.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product and Solutions
2.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
2.8 Autolus Therapeutics(Pipeline)
2.8.1 Autolus Therapeutics(Pipeline) Details
2.8.2 Autolus Therapeutics(Pipeline) Major Business
2.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
2.8.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Autolus Therapeutics(Pipeline) Recent Developments and Future Plans
2.9 Sorrento Therapeutics(Pipeline)
2.9.1 Sorrento Therapeutics(Pipeline) Details
2.9.2 Sorrento Therapeutics(Pipeline) Major Business
2.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
2.9.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sorrento Therapeutics(Pipeline) Recent Developments and Future Plans
2.10 Mustang Bio(Pipeline)
2.10.1 Mustang Bio(Pipeline) Details
2.10.2 Mustang Bio(Pipeline) Major Business
2.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
2.10.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Mustang Bio(Pipeline) Recent Developments and Future Plans
2.11 Bluebird Bio(Pipeline)
2.11.1 Bluebird Bio(Pipeline) Details
2.11.2 Bluebird Bio(Pipeline) Major Business
2.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
2.11.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bluebird Bio(Pipeline) Recent Developments and Future Plans
2.12 Cellectis(Pipeline)
2.12.1 Cellectis(Pipeline) Details
2.12.2 Cellectis(Pipeline) Major Business
2.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Product and Solutions
2.12.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Cellectis(Pipeline) Recent Developments and Future Plans
2.13 Allogene Therapeutics(Pipeline)
2.13.1 Allogene Therapeutics(Pipeline) Details
2.13.2 Allogene Therapeutics(Pipeline) Major Business
2.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
2.13.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Allogene Therapeutics(Pipeline) Recent Developments and Future Plans
2.14 Celyad(Pipeline)
2.14.1 Celyad(Pipeline) Details
2.14.2 Celyad(Pipeline) Major Business
2.14.3 Celyad(Pipeline) CAR T-Cell Therapy Product and Solutions
2.14.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Celyad(Pipeline) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global CAR T-Cell Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of CAR T-Cell Therapy by Company Revenue
3.2.2 Top 3 CAR T-Cell Therapy Players Market Share in 2023
3.2.3 Top 6 CAR T-Cell Therapy Players Market Share in 2023
3.3 CAR T-Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 CAR T-Cell Therapy Market: Region Footprint
3.3.2 CAR T-Cell Therapy Market: Company Product Type Footprint
3.3.3 CAR T-Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global CAR T-Cell Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global CAR T-Cell Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global CAR T-Cell Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America CAR T-Cell Therapy Consumption Value by Type (2019-2030)
6.2 North America CAR T-Cell Therapy Market Size by Application (2019-2030)
6.3 North America CAR T-Cell Therapy Market Size by Country
6.3.1 North America CAR T-Cell Therapy Consumption Value by Country (2019-2030)
6.3.2 United States CAR T-Cell Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada CAR T-Cell Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe CAR T-Cell Therapy Consumption Value by Type (2019-2030)
7.2 Europe CAR T-Cell Therapy Consumption Value by Application (2019-2030)
7.3 Europe CAR T-Cell Therapy Market Size by Country
7.3.1 Europe CAR T-Cell Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7.3.3 France CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Region
8.3.1 Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2019-2030)
8.3.2 China CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.5 India CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America CAR T-Cell Therapy Consumption Value by Type (2019-2030)
9.2 South America CAR T-Cell Therapy Consumption Value by Application (2019-2030)
9.3 South America CAR T-Cell Therapy Market Size by Country
9.3.1 South America CAR T-Cell Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil CAR T-Cell Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina CAR T-Cell Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Country
10.3.1 Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey CAR T-Cell Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE CAR T-Cell Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 CAR T-Cell Therapy Market Drivers
11.2 CAR T-Cell Therapy Market Restraints
11.3 CAR T-Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 CAR T-Cell Therapy Industry Chain
12.2 CAR T-Cell Therapy Upstream Analysis
12.3 CAR T-Cell Therapy Midstream Analysis
12.4 CAR T-Cell Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global CAR T-Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global CAR T-Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global CAR T-Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis CAR T-Cell Therapy Product and Solutions
Table 8. Novartis CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences CAR T-Cell Therapy Product and Solutions
Table 13. Gilead Sciences CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Gilead Sciences Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb CAR T-Cell Therapy Product and Solutions
Table 18. Bristol-Myers Squibb CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. J & J Company Information, Head Office, and Major Competitors
Table 20. J & J Major Business
Table 21. J & J CAR T-Cell Therapy Product and Solutions
Table 22. J & J CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. J & J Recent Developments and Future Plans
Table 24. JW Therapeutics Company Information, Head Office, and Major Competitors
Table 25. JW Therapeutics Major Business
Table 26. JW Therapeutics CAR T-Cell Therapy Product and Solutions
Table 27. JW Therapeutics CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. JW Therapeutics Recent Developments and Future Plans
Table 29. FOSUNKite Company Information, Head Office, and Major Competitors
Table 30. FOSUNKite Major Business
Table 31. FOSUNKite CAR T-Cell Therapy Product and Solutions
Table 32. FOSUNKite CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. FOSUNKite Recent Developments and Future Plans
Table 34. CARsgen Therapeutics (Pipeline) Company Information, Head Office, and Major Competitors
Table 35. CARsgen Therapeutics (Pipeline) Major Business
Table 36. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product and Solutions
Table 37. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
Table 39. Autolus Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
Table 40. Autolus Therapeutics(Pipeline) Major Business
Table 41. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 42. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Autolus Therapeutics(Pipeline) Recent Developments and Future Plans
Table 44. Sorrento Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
Table 45. Sorrento Therapeutics(Pipeline) Major Business
Table 46. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 47. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Sorrento Therapeutics(Pipeline) Recent Developments and Future Plans
Table 49. Mustang Bio(Pipeline) Company Information, Head Office, and Major Competitors
Table 50. Mustang Bio(Pipeline) Major Business
Table 51. Mustang Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 52. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. Mustang Bio(Pipeline) Recent Developments and Future Plans
Table 54. Bluebird Bio(Pipeline) Company Information, Head Office, and Major Competitors
Table 55. Bluebird Bio(Pipeline) Major Business
Table 56. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 57. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. Bluebird Bio(Pipeline) Recent Developments and Future Plans
Table 59. Cellectis(Pipeline) Company Information, Head Office, and Major Competitors
Table 60. Cellectis(Pipeline) Major Business
Table 61. Cellectis(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 62. Cellectis(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 63. Cellectis(Pipeline) Recent Developments and Future Plans
Table 64. Allogene Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
Table 65. Allogene Therapeutics(Pipeline) Major Business
Table 66. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 67. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 68. Allogene Therapeutics(Pipeline) Recent Developments and Future Plans
Table 69. Celyad(Pipeline) Company Information, Head Office, and Major Competitors
Table 70. Celyad(Pipeline) Major Business
Table 71. Celyad(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 72. Celyad(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 73. Celyad(Pipeline) Recent Developments and Future Plans
Table 74. Global CAR T-Cell Therapy Revenue (USD Million) by Players (2019-2024)
Table 75. Global CAR T-Cell Therapy Revenue Share by Players (2019-2024)
Table 76. Breakdown of CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in CAR T-Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 78. Head Office of Key CAR T-Cell Therapy Players
Table 79. CAR T-Cell Therapy Market: Company Product Type Footprint
Table 80. CAR T-Cell Therapy Market: Company Product Application Footprint
Table 81. CAR T-Cell Therapy New Market Entrants and Barriers to Market Entry
Table 82. CAR T-Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global CAR T-Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 84. Global CAR T-Cell Therapy Consumption Value Share by Type (2019-2024)
Table 85. Global CAR T-Cell Therapy Consumption Value Forecast by Type (2025-2030)
Table 86. Global CAR T-Cell Therapy Consumption Value by Application (2019-2024)
Table 87. Global CAR T-Cell Therapy Consumption Value Forecast by Application (2025-2030)
Table 88. North America CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 89. North America CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 90. North America CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 91. North America CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 92. North America CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 93. North America CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Europe CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 95. Europe CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 96. Europe CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Europe CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Europe CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 99. Europe CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 106. South America CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 107. South America CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 108. South America CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 109. South America CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 110. South America CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 113. Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 114. Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 115. Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 116. Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 117. Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Global Key Players of CAR T-Cell Therapy Upstream (Raw Materials)
Table 119. Global CAR T-Cell Therapy Typical Customers
Table 1. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global CAR T-Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global CAR T-Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global CAR T-Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis CAR T-Cell Therapy Product and Solutions
Table 8. Novartis CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences CAR T-Cell Therapy Product and Solutions
Table 13. Gilead Sciences CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Gilead Sciences Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb CAR T-Cell Therapy Product and Solutions
Table 18. Bristol-Myers Squibb CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. J & J Company Information, Head Office, and Major Competitors
Table 20. J & J Major Business
Table 21. J & J CAR T-Cell Therapy Product and Solutions
Table 22. J & J CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. J & J Recent Developments and Future Plans
Table 24. JW Therapeutics Company Information, Head Office, and Major Competitors
Table 25. JW Therapeutics Major Business
Table 26. JW Therapeutics CAR T-Cell Therapy Product and Solutions
Table 27. JW Therapeutics CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. JW Therapeutics Recent Developments and Future Plans
Table 29. FOSUNKite Company Information, Head Office, and Major Competitors
Table 30. FOSUNKite Major Business
Table 31. FOSUNKite CAR T-Cell Therapy Product and Solutions
Table 32. FOSUNKite CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. FOSUNKite Recent Developments and Future Plans
Table 34. CARsgen Therapeutics (Pipeline) Company Information, Head Office, and Major Competitors
Table 35. CARsgen Therapeutics (Pipeline) Major Business
Table 36. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product and Solutions
Table 37. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
Table 39. Autolus Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
Table 40. Autolus Therapeutics(Pipeline) Major Business
Table 41. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 42. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Autolus Therapeutics(Pipeline) Recent Developments and Future Plans
Table 44. Sorrento Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
Table 45. Sorrento Therapeutics(Pipeline) Major Business
Table 46. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 47. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Sorrento Therapeutics(Pipeline) Recent Developments and Future Plans
Table 49. Mustang Bio(Pipeline) Company Information, Head Office, and Major Competitors
Table 50. Mustang Bio(Pipeline) Major Business
Table 51. Mustang Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 52. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. Mustang Bio(Pipeline) Recent Developments and Future Plans
Table 54. Bluebird Bio(Pipeline) Company Information, Head Office, and Major Competitors
Table 55. Bluebird Bio(Pipeline) Major Business
Table 56. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 57. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. Bluebird Bio(Pipeline) Recent Developments and Future Plans
Table 59. Cellectis(Pipeline) Company Information, Head Office, and Major Competitors
Table 60. Cellectis(Pipeline) Major Business
Table 61. Cellectis(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 62. Cellectis(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 63. Cellectis(Pipeline) Recent Developments and Future Plans
Table 64. Allogene Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
Table 65. Allogene Therapeutics(Pipeline) Major Business
Table 66. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 67. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 68. Allogene Therapeutics(Pipeline) Recent Developments and Future Plans
Table 69. Celyad(Pipeline) Company Information, Head Office, and Major Competitors
Table 70. Celyad(Pipeline) Major Business
Table 71. Celyad(Pipeline) CAR T-Cell Therapy Product and Solutions
Table 72. Celyad(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 73. Celyad(Pipeline) Recent Developments and Future Plans
Table 74. Global CAR T-Cell Therapy Revenue (USD Million) by Players (2019-2024)
Table 75. Global CAR T-Cell Therapy Revenue Share by Players (2019-2024)
Table 76. Breakdown of CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in CAR T-Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 78. Head Office of Key CAR T-Cell Therapy Players
Table 79. CAR T-Cell Therapy Market: Company Product Type Footprint
Table 80. CAR T-Cell Therapy Market: Company Product Application Footprint
Table 81. CAR T-Cell Therapy New Market Entrants and Barriers to Market Entry
Table 82. CAR T-Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global CAR T-Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 84. Global CAR T-Cell Therapy Consumption Value Share by Type (2019-2024)
Table 85. Global CAR T-Cell Therapy Consumption Value Forecast by Type (2025-2030)
Table 86. Global CAR T-Cell Therapy Consumption Value by Application (2019-2024)
Table 87. Global CAR T-Cell Therapy Consumption Value Forecast by Application (2025-2030)
Table 88. North America CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 89. North America CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 90. North America CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 91. North America CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 92. North America CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 93. North America CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Europe CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 95. Europe CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 96. Europe CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Europe CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Europe CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 99. Europe CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 106. South America CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 107. South America CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 108. South America CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 109. South America CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 110. South America CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 113. Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 114. Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 115. Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 116. Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 117. Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Global Key Players of CAR T-Cell Therapy Upstream (Raw Materials)
Table 119. Global CAR T-Cell Therapy Typical Customers
LIST OF FIGURES
Figure 1. CAR T-Cell Therapy Picture
Figure 2. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global CAR T-Cell Therapy Consumption Value Market Share by Type in 2023
Figure 4. CD19 - Targeted
Figure 5. BCMA - Targeted
Figure 6. Global CAR T-Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. CAR T-Cell Therapy Consumption Value Market Share by Application in 2023
Figure 8. Lymphoma Picture
Figure 9. Multiple Myeloma Picture
Figure 10. Global CAR T-Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global CAR T-Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market CAR T-Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 13. Global CAR T-Cell Therapy Consumption Value Market Share by Region (2019-2030)
Figure 14. Global CAR T-Cell Therapy Consumption Value Market Share by Region in 2023
Figure 15. North America CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 18. South America CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East & Africa CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global CAR T-Cell Therapy Revenue Share by Players in 2023
Figure 22. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 23. Market Share of CAR T-Cell Therapy by Player Revenue in 2023
Figure 24. Top 3 CAR T-Cell Therapy Players Market Share in 2023
Figure 25. Top 6 CAR T-Cell Therapy Players Market Share in 2023
Figure 26. Global CAR T-Cell Therapy Consumption Value Share by Type (2019-2024)
Figure 27. Global CAR T-Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 28. Global CAR T-Cell Therapy Consumption Value Share by Application (2019-2024)
Figure 29. Global CAR T-Cell Therapy Market Share Forecast by Application (2025-2030)
Figure 30. North America CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 31. North America CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 32. North America CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 33. United States CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. France CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Region (2019-2030)
Figure 47. China CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 50. India CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. South America CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 54. South America CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 55. South America CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East & Africa CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East & Africa CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East & Africa CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 64. CAR T-Cell Therapy Market Drivers
Figure 65. CAR T-Cell Therapy Market Restraints
Figure 66. CAR T-Cell Therapy Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. CAR T-Cell Therapy Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. CAR T-Cell Therapy Picture
Figure 2. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global CAR T-Cell Therapy Consumption Value Market Share by Type in 2023
Figure 4. CD19 - Targeted
Figure 5. BCMA - Targeted
Figure 6. Global CAR T-Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. CAR T-Cell Therapy Consumption Value Market Share by Application in 2023
Figure 8. Lymphoma Picture
Figure 9. Multiple Myeloma Picture
Figure 10. Global CAR T-Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global CAR T-Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market CAR T-Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 13. Global CAR T-Cell Therapy Consumption Value Market Share by Region (2019-2030)
Figure 14. Global CAR T-Cell Therapy Consumption Value Market Share by Region in 2023
Figure 15. North America CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 18. South America CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East & Africa CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global CAR T-Cell Therapy Revenue Share by Players in 2023
Figure 22. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 23. Market Share of CAR T-Cell Therapy by Player Revenue in 2023
Figure 24. Top 3 CAR T-Cell Therapy Players Market Share in 2023
Figure 25. Top 6 CAR T-Cell Therapy Players Market Share in 2023
Figure 26. Global CAR T-Cell Therapy Consumption Value Share by Type (2019-2024)
Figure 27. Global CAR T-Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 28. Global CAR T-Cell Therapy Consumption Value Share by Application (2019-2024)
Figure 29. Global CAR T-Cell Therapy Market Share Forecast by Application (2025-2030)
Figure 30. North America CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 31. North America CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 32. North America CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 33. United States CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. France CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Region (2019-2030)
Figure 47. China CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 50. India CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. South America CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 54. South America CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 55. South America CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East & Africa CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East & Africa CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East & Africa CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
Figure 64. CAR T-Cell Therapy Market Drivers
Figure 65. CAR T-Cell Therapy Market Restraints
Figure 66. CAR T-Cell Therapy Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. CAR T-Cell Therapy Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
